Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03934944
Other study ID # RA HM-2018_044
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 10, 2019
Est. completion date April 2023

Study information

Verified date August 2021
Source Dasman Diabetes Institute
Contact Kay Scarsbrook Khan, BSc
Phone +965 22242999
Email kay.khan@dasmaninstitute.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare foot care knowledge, behaviour and glycaemic control in patients at increased risk of diabetic foot ulcers. Participants will receive either usual diabetic foot care education and follow-up as per evidence-based guidelines or usual care and follow-up, supplemented with an educational video and weekly foot alerts via a phone application.


Description:

It is recommended that patients who are at moderate or high risk of diabetic foot ulcer (DFU) are seen by a healthcare professional for foot review every 2-6 months. Yet, diabetic foot ulcers remain the leading cause of non-traumatic lower limb amputation with an amputation occurring every 20 secs. This suggests that additional information and prompts, as well as regular follow-up, are required. Additionally, long term diabetic foot complications including loss of protective pain sensation are related to poor glycaemic control. This single blinded randomised study aims to determine if weekly foot alerts (a total of 12 alerts cycled over 12-months), delivered by the MyU phone application in combination with usual education routes and follow-up, improves patient foot care behaviour and foot care knowledge. Using standardized questionnaires at baseline and 12-months. Furthermore, does the frequency of viewing/engaging in foot alert content influence foot care knowledge and behaviour. Secondary objectives are to determine: 1) if individuals who receive 7-foot review appointments in a 12-month period have better foot care knowledge and behaviour when compared to those seen less frequently regardless of educational route. 2) Baseline and 12-months HbA1c blood test will be measured to establish if any changes occurred between the two groups. Expected results: The investigators hypothesized that participants randomised to the intervention group (Phone app) will have improved foot care knowledge and foot health behaviours. Sample size: 100 patients with a 1:1 ratio Quality Assurance: A standard operating procedure based on established diabetic foot screening tools will be used to ensure the inter-rater reliability of foot assessment. Educational material will go through back translation to ensure the accuracy of the content. Feedback on content, meaning and usability of the English and Arabic documents from a sample of 10 participants will be sought. To maintain investigator blinding the participants will be escorted to the video viewing room by a research coordinator.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date April 2023
Est. primary completion date February 2023
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Male or female 21 yrs or - Type 2 Diabetes Mellitus or Type 1 Diabetes Mellitus greater than 5-yrs - At least one diabetic foot risk factor (i.e Loss of Pain Sensation Peripheral Arterial Disease etc) - Ability to understand Arabic or English to a skill listening level 3 and speaking level +2 (Interagency Language Roundtable). - Own a smartphone and access to the internet - The ability to understand the study procedures and to comply with them for the entire length of the study - Resident in Kuwait Exclusion Criteria: - Chronic kidney disease stage 3 or above - Cognitive impairment - Acute psychiatric illness - Hearing or visual impairment that would mean the intervention would not be understood - phone application inaccessible for more than 4 continuous weeks - Refusal to give written informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Phone application
Weekly foot alerts and educational video
Other:
Usual care
Usual routine of diabetic foot education

Locations

Country Name City State
Kuwait Dasman Diabetes Institute Kuwait

Sponsors (2)

Lead Sponsor Collaborator
Dasman Diabetes Institute Kuwait Foundation for the Advancement of Sciences

Country where clinical trial is conducted

Kuwait, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in foot care knowledge as measured by the adapted foot care knowledge test Change in the adapted Diabetic Foot Care Knowledge test (Pollock et al. 2004 and Rheeder et al. 2008) score between baseline and 12-months in the two groups This 12-question test has a maximum score of 12, and a minimum score of 0. Each correct answer is given one point, where a low score denotes low knowledge and high score denotes high knowledge. For each group a mean will be calculated and significance of differences will be tested using the students two tailed unpaired T-Test. 12 months
Primary Change in foot care behaviour as measured by the SDSCA SDCS questionnaire includes a number of domains which evaluate different aspects of patient behaviour performed during the previous week. Each domain has one or more questions that are marked between 0-7. The domains are:
Foot care: total of 9 questions with maximum score 9x7 = 63, the greater the score the better the behaviour
Diabetes Management: 4 questions in diabetes management, maximum score 4x7 = 28, the greater the score the better the behaviour
Smoking habits: number of cigarettes per day, the greater the number the worse the behaviour
These measures allow formulation of a composite reflection in changes in the patient's behaviour between baseline and 12-months in the two groups. Differences will be tested using the students two-tailed unpaired T-Test.
12 months
Secondary Change in HbA1c from baseline Change in HbA1c measurement taken from venous blood supply at baseline and 12-months between intervention and control group. 12 months
Secondary Proportion of participants who developed a new diabetic foot ulcer Case report form. Diabetic foot ulcer is defined as a wound below the ankle in someone with diabetes and will be classified using the University of Texas Wound classification System. 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04497805 - Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers Phase 2
Withdrawn NCT03675269 - Adjunctive Hyperbaric Oxygen Therapy (HBOT) for Lower Extermity Diabetic Ulcer: N/A
Completed NCT04624516 - Effect of Self-foot Exercise on the Incidence of Plantar Foot Diabetic Ulcer Recurrence N/A
Not yet recruiting NCT06439667 - VIRTUALLY SUPERVISED TELE-EXERCISE PLATFORM FOR ACCELERATING PLANTAR WOUND HEALING
Recruiting NCT05608187 - Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers Phase 2
Not yet recruiting NCT06437028 - Evaluating the Efficacy of Perinatal Membrane Allografts for the Treatment of Diabetic Foot Ulcers. N/A
Not yet recruiting NCT06278935 - Lifestyle Tailored Offloading for Diabetic Foot Ulcers N/A
Withdrawn NCT05024656 - AmnioExcel® Plus vs SOC in the Management of Diabetic Foot Ulcers N/A
Terminated NCT02202668 - Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers N/A
Completed NCT01951768 - Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection Phase 4
Terminated NCT01966380 - Proof of Concept (Design Validation) in Patient With Hard to Heal Wounds Such as Pressure Ulcer, Diabetic Foot Ulcer and Leg Ulcer, Leia Phase 2
Completed NCT01657474 - Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers N/A
Active, not recruiting NCT00389636 - TheraGauzeā„¢ Alone and Regranex®Gel 0.01% Plus TheraGauzeā„¢ in the Treatment of Wagner Stage I Diabetic Foot Ulcers N/A
Completed NCT01181440 - Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers Phase 3
Enrolling by invitation NCT05888259 - Plantar Pressure Distribution in Diabetic Foot Ulcer N/A
Completed NCT04054804 - Digital Foot Check by Using the D-Foot, a New Software
Not yet recruiting NCT05877378 - Efficacy of PICO Single-use System in Chronic Ulcers N/A
Recruiting NCT06037369 - The Short Message-based Customized Standardized N/A
Completed NCT03312595 - Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) N/A
Recruiting NCT04564443 - A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot N/A